Ai et al. recently showed that cisplatin induced HIF-1α degradation in cisplatin-sensitive ovarian cancer cells, but did not downregulate HIF-1α in their cisplatin-resistant counterpart, indicating that HIF-1α downregulation is an important mediator in the response to cisplatin [11]. This evidence concerns the gene HIF1A and ovarian cancer.